Sandbox Reserved 966
From Proteopedia
(Difference between revisions)
| Line 18: | Line 18: | ||
In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. | In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. | ||
First, they try to treat strabismus and in the late 1970s the neurotoxin is used in many therapeutic applications. | First, they try to treat strabismus and in the late 1970s the neurotoxin is used in many therapeutic applications. | ||
| - | === hyperhidrosis and CHARGE syndrome <ref>http://rms.medhyg.ch/numero-200-page-870.htm<\ref> | + | === hyperhidrosis and CHARGE syndrome === |
| - | + | We can now treat excessive sweating with botulinium toxin <ref>http://rms.medhyg.ch/numero-200-page-870.htm<\ref> thanks to his action on the receptors of the parasympathetic network. Excessive dribbling can be treated in the same way. | |
=== Cosmetic === | === Cosmetic === | ||
Non-lethal amount of botulinum toxin can be injected localy to paralyse targeted muscles and reduce wrinkles temporaly (5 to 6 months). | Non-lethal amount of botulinum toxin can be injected localy to paralyse targeted muscles and reduce wrinkles temporaly (5 to 6 months). | ||
Revision as of 19:38, 4 January 2015
| This Sandbox is Reserved from 15/11/2014, through 15/05/2015 for use in the course "Biomolecule" taught by Bruno Kieffer at the Strasbourg University. This reservation includes Sandbox Reserved 951 through Sandbox Reserved 975. |
To get started:
More help: Help:Editing |
Structure of the "Clostridium botulinum" neurotoxin serotype A light chain with Zn2+ cofactor bound
| |||||||||||
